Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
special purpose acquisition company
Biotech
Preclinical stem cell biotech takes SPAC route to Nasdaq
Stem cell therapy biotech PrimeGen US is taking the less-traveled SPAC route to the public markets.
James Waldron
Feb 4, 2026 10:15am
Freenome to go public in $330M SPAC deal
Dec 5, 2025 10:35am
Singapore drug discovery platform heads to Nasdaq via SPAC deal
Oct 2, 2025 9:50am
Minovia skates SPAC-wards into public market
Jun 25, 2025 10:33am
German cancer antibody biotech eyes SPAC as route to Nasdaq
Apr 23, 2025 6:09am
BridgeBio's cancer spinout backs SPAC as path to Nasdaq
Feb 28, 2025 9:25am
